Related Experiment Video
Updated: Jul 4, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Vesicoureteric reflux is not a benign condition
Insights
Renal scarring from vesicoureteric reflux (VUR) can occur rapidly in infants, even before urinary tract infections (UTIs) are diagnosed. Current guidelines recommending less intervention are challenged; more diligent management is needed to prevent kidney damage.
Area of Science:
- Pediatric Nephrology
- Urology
- Medical Research
Background:
- Renal parenchymal defects are linked to congenital causes or acquired reflux nephropathy from VUR and UTIs.
- A piglet model showed 70% of infants with VUR and vulnerable pyramids scar rapidly after their first UTI.
Discussion:
- Current guidelines suggest congenital origins for defects, downplaying VUR's causal role and advocating less intervention.
- This perspective overlooks evidence of rapid scarring in infant kidneys, even before UTI diagnosis, and that reflux nephropathy affects all ages.
Key Insights:
- Reflux nephropathy can develop quickly in infants, challenging the notion of congenital defects as the sole cause.
- The rarity of scarring after age 4 suggests early vulnerability and rapid progression.
- Adult evidence and clinical data indicate reflux nephropathy has no age limit.
Outlook:
- Preventing renal scarring requires improved infant UTI diagnosis and prompt treatment.
- Reliable imaging for scars and VUR, alongside protective measures until VUR resolution, are crucial.
- A more assiduous management approach is necessary, recognizing VUR as a potentially serious condition.
Abstract:
Renal parenchymal defects may be congenital, usually associated with dilated vesicoureteric reflux (VUR), or they may appear in previously normal kidneys and be caused by reflux nephropathy due to VUR combined with urinary tract infection (UTI). A piglet model defined that the 70% of children with VUR and vulnerable pyramids would scar rapidly with their first UTI. Because most defects are present at first imaging after a UTI, and from the lack of benefit from apparently reasonable clinical interventions, many now believe that most defects are congenital, their association with VUR being a shared dysplasia rather than causal. Consequently, guidelines now argue for less assiduous management. These conclusions ignore adult human transplant evidence, adult pig studies, and clinical anecdotes, which indicate that scars may develop in infant kidneys quicker than urine culture can confirm the diagnosis, and that reflux nephropathy has no age limit. Its rarity over 4 years suggests that most vulnerable children develop scars before then, despite all medical efforts. I argue that preventing such scarring will require better diagnosis of infant UTI, quicker treatment, reliable imaging of scars and VUR, and subsequent protection until VUR resolves. To make a difference, we need more assiduous management, not less, and cannot afford to consider VUR to be a benign condition.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Ureters
Urinary Tract Infection I: Introduction

